Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 135.63B | 135.63B | 129.29B | 109.33B | 109.64B | 117.22B |
Gross Profit | 23.01B | 23.01B | 18.79B | 15.53B | 15.77B | 17.63B |
EBITDA | 13.47B | 13.59B | 8.96B | 6.75B | 7.56B | 9.09B |
Net Income | 8.22B | 8.22B | 5.05B | 3.79B | 4.54B | 5.59B |
Balance Sheet | ||||||
Total Assets | 130.84B | 130.84B | 122.12B | 116.08B | 93.10B | 95.42B |
Cash, Cash Equivalents and Short-Term Investments | 22.10B | 22.10B | 11.16B | 9.35B | 9.95B | 10.46B |
Total Debt | 18.56B | 18.56B | 20.24B | 29.89B | 10.01B | 10.62B |
Total Liabilities | 72.95B | 72.95B | 69.95B | 68.21B | 47.57B | 53.21B |
Stockholders Equity | 57.88B | 57.88B | 52.17B | 47.87B | 45.53B | 42.21B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 14.95B | 13.83B | -18.31B | 1.31B | -4.41B |
Operating Cash Flow | 0.00 | 15.95B | 15.94B | -16.71B | 2.60B | -3.68B |
Investing Cash Flow | 0.00 | -807.00M | -1.92B | -1.96B | -1.15B | -675.00M |
Financing Cash Flow | 0.00 | -4.21B | -12.22B | 18.06B | -1.97B | -664.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥86.92B | 10.77 | ― | 3.87% | 3.55% | 36.89% | |
77 Outperform | 99.81B | 13.09 | 8.20% | 2.59% | 27.51% | 11.09% | |
75 Outperform | 77.25B | 22.19 | 5.16% | 3.39% | -10.85% | ― | |
75 Outperform | 163.81B | 18.34 | 10.78% | 5.05% | 0.57% | 26.93% | |
69 Neutral | 120.60B | 14.97 | 6.52% | 3.30% | 11.42% | 26.72% | |
69 Neutral | 109.80B | 17.53 | 4.69% | 2.30% | 6.90% | -25.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |